Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects

NCT02117830 is registered in ClinicalTrials.gov with Repros Therapeutics Inc. as lead sponsor.

NCT NCT02117830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02117830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects
Lead sponsor
Repros Therapeutics Inc.
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2014
Completion date
Not reported
Enrollment
54 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy